Drug Cases -

Zantac and Singulair Cases

Beck Law Center is a pioneer in pharmaceutical cases.  Kim Beck filed some of the earliest Zantac Cases.  As of Mid-September 2021, Beck Law Center has the only filed Singulair cases.

Zantac package

Zantac

Zantac and its active ingredient ranitidine have been sold in the United States since 1983, originally only as a prescription, and later also as an over the counter treatment for acid indigestion, heartburn, and sour stomach.  Tens of thousands of people used Zantac every year, not knowing the extent of its danger.

Singulair Tab

Singulair

Singulair has been on the market since 1998.  It is "indicated for" (meaning it is supposed to treat) asthma, hay fever and allergies.  From 1998 on, Merck has received reports of neuropsychiatric injuries, like OCD, depression, tics, tremors, and suidicality.  Regardless, Merck has played down Singulair's risks.

 

Finally in March of 2020, the FDA forced Merck to add a "Black Box Warning" to Singulair's label.  This is the strongest kind of warning the FDA can require.

You always have access to your case file.

All your legal information is in one spot on our website, and you can see it whenever you want.

"It's like MyChart for your case!"

As a client of Beck Law Center, you can log in through the website to see your case files.  You can also send and receive case specific messages from team members.  Current clients can sign in here.

Let's talk about your case.

You can contact us at information@becklawcenter.com, 888-434-2912, or by filling out the form below.

Please enter your name.
Please enter a valid email.
Please enter a message.